Shalini Shenoy
Washington University School of Medicine · Washington University School of Medicine (in St. Louis)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shalini Shenoy as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:38 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT03128996 · Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant DisordersWashington University School of Medicine · recruiting · Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders · principal investigator
- Ph2NCT01005576 · Reduced Intensity Transplant Conditioning Regimen for Severe ThalassemiaWashington University School of Medicine · completed · Severe Thalassemia · principal investigator
- Ph1/Ph2NCT00920972 · Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant DiseasesWashington University School of Medicine · recruiting · Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Seventh Annual PBMTC Educational Meeting: Advances in Cancer Therapy relating to Stem Cell TransplantationR13CA239607 · NCI · WASHINGTON UNIVERSITY · fiscal years 2019 · $5,000 awarded in 2019Same name and institution; not confirmed by an ID
- MINOR ANTIGENS IN BONE MARROW TRANSPLANTATIONK08CA072587 · NCI · WASHINGTON UNIVERSITY · fiscal years 1997 to 2001 · $87,511 awarded in 2001Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:38 UTC. The ranking covers the 200 most relevant of 73 PubMed records, and a shared surname and initials can bring in a namesake. All 73 on PubMed
- 475 citationsRCR 40.0
- A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.Transplantation · 1999274 citationsRCR 8.1
- Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation.Int J Clin Pharmacol Ther Toxicol · 1986251 citationsRCR 7.8
- Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.J Clin Oncol · 2021231 citationsRCR 14.2
- A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.Blood · 2016171 citationsRCR 6.7
- Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).Biol Blood Marrow Transplant · 2012151 citationsRCR 4.5
- Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.Blood · 2007115 citationsRCR 2.3
- Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation.Transplantation · 200486 citationsRCR 2.4
- Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.Blood · 201885 citationsRCR 3.5
- Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.Pediatr Blood Cancer · 200880 citationsRCR 2.4